Charles Schwab’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.73M | Buy |
331,539
+98,389
| +42% | +$1.11M | ﹤0.01% | 2457 |
|
|
2025
Q1 | $1.33M | Sell |
233,150
-567
| -0.2% | -$3.23K | ﹤0.01% | 2745 |
|
|
2024
Q4 | $2.3M | Buy |
233,717
+17,372
| +8% | +$171K | ﹤0.01% | 2633 |
|
|
2024
Q3 | $1.76M | Buy |
216,345
+49,210
| +29% | +$401K | ﹤0.01% | 2746 |
|
|
2024
Q2 | $2.23M | Sell |
167,135
-30,179
| -15% | -$404K | ﹤0.01% | 2677 |
|
|
2024
Q1 | $9.16M | Buy |
197,314
+5,781
| +3% | +$268K | ﹤0.01% | 2028 |
|
|
2023
Q4 | $12.9M | Buy |
191,533
+6,073
| +3% | +$411K | ﹤0.01% | 1856 |
|
|
2023
Q3 | $13.4M | Buy |
185,460
+38,852
| +27% | +$2.81M | ﹤0.01% | 1752 |
|
|
2023
Q2 | $10.9M | Buy |
146,608
+12,862
| +10% | +$957K | ﹤0.01% | 1875 |
|
|
2023
Q1 | $7.12M | Buy |
133,746
+15,638
| +13% | +$832K | ﹤0.01% | 2038 |
|
|
2022
Q4 | $7.98M | Buy |
118,108
+18,090
| +18% | +$1.22M | ﹤0.01% | 1980 |
|
|
2022
Q3 | $12.5M | Buy |
100,018
+34,851
| +53% | +$4.35M | ﹤0.01% | 1689 |
|
|
2022
Q2 | $6.2M | Sell |
65,167
-9,812
| -13% | -$934K | ﹤0.01% | 2095 |
|
|
2022
Q1 | $12.1M | Buy |
74,979
+712
| +1% | +$115K | ﹤0.01% | 1838 |
|
|
2021
Q4 | $24.7M | Buy |
+74,267
| New | +$24.7M | 0.01% | 1408 |
|